ABSTRACT
Metabolic syndrome (MetS) is dened by a cluster of cardiovascular disease risk factors that are associated with insulin resistance (Adults Treatment Panel III 2001, Pratley 2007) and is a strong predictor of cardiovascular disease as well as type 2 diabetes (Grassi et al. 2013b). Early detection and treatment of people with MetS may prevent the development of cardiovascular disease and type 2 diabetes.
